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A healthy 8-year-old girl presented with multiple punctate and 
arborizing telangiectasias, which were surrounded by anemic 
halos, developed progressively from 2  months of age. They 
favoured sun-exposed areas of the face, neck, upper, and lower 
extremities. There was no associated mucosal involvement, clin-
ical evidence of bleeding diathesis, or systemic involvement. 
There was no family history of similar lesions. Dermoscopy 
showed a linear branched vascular pattern that disappeared 
with compression. No homogeneous brownish background 
was observed on dermoscopy. What is the diagnosis?
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ANSWER: HEREDITARY BENIGN TELANGI- 
ECTASIA (HBT)
HBT is an uncommon, genetically inherited, benign skin disor-
der with onset in childhood (1).
Clinically, HBT is characterized by the presence of telangiecta-
sias with different morphological features, such as punctate, linear, 
or arborizing. They are surrounded by anemic halos on sun-ex-
posed areas of the face, neck, upper trunk, and upper extremities. 
With the exception of the vermilion lips and palate, mucous mem-
branes are not involved and there is no visceral involvement (2,3).
The main differential diagnoses include capillary malforma-
tions–arteriovenous malformation (CM-AVM) syndrome, an 
autosomal dominant disease due to a mutation in the RASA1 
gene. This condition is characterized by capillary malforma-
tions often present at birth, telangiectasias with a background 
of hyperpigmentation and surrounding pale halo scattered 
throughout the body, as well as fast-flow AVMs and AV fistulas 
that can be presented in approximately 35% of patients (3–5). 
Due to the similar morphology and distribution of lesions 
between CM-AVM syndrome and HBT we cannot completely 
exclude the former. Still, in this case, telangiectasias favoured 
sun-exposed areas. This distribution of cutaneous lesions is 
often found in HBT (1,3). On dermoscopy, we did not observe 
thumbprint-like capillary malformations, which is a character-
istic skin finding in CM-AVM syndrome (5). Also, we did not 
observe a homogeneous brown background in telangiectasias, 
which is a dermoscopic characteristic of cutaneous CM in 
CM-AVM syndrome that may result from involvement of mast 
cells (4). Moreover, we excluded the presence of intracranial 
AVMs by brain MRI and there is no evidence of other AVMs. 
These findings make CM-AVM syndrome less likely than HBT. 
Another diagnoses ruled out includes hereditary hemorrhagic 
telangiectasia (Rendu-Osler-Weber disease), which presents 
with mucosal and visceral involvement associated with repeated 
episodes of epistaxis in children, before the appearance of cuta-
neous telangiectasias during adolescence or even later in life. 
Additionally, essential generalized telangiectasia was also ruled 
out since it typically affects adult women with blanchable telan-
giectasias of the distal lower extremities, that progresses upward 
toward trunk and upper extremities (1,5,6).
We considered this case a nonhereditary form of HBT given 
the absence of family history of HBT (2).
HBT has a good prognosis (1). If the lesions constitute a cos-
metic issue, electrocautery, laser treatments, and intense pulsed 
light are possible treatment approaches (7).
Since it is not possible to completely exclude the diagnosis 
of CM-AVM syndrome, we keep this child in a close medical 
follow-up. This question may be clarified if genetic testing for 
RASA1 gene becomes available in the future.
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